Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-17

Clinical Trial Update: Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel and cisplatin with radiation therapy followed by filgrastim in patients with recurrent head and neck cancer or lung cancer h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Filgrastim (filgrastim)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Head and Neck Cancer, Lung Cancer | Phase 2 | Status: COMPLETED